BB Biotech AG : Publication pursuant to §26a WpHG (the German Securities Trading Act) with the aim of pan-European distribution
Pursuant to article 26a WpHG, BB Biotech AG, Schwertstrasse 6, 8200 Schaffhausen, Switzerland, hereby announces that the total voting rights from July 12, 2016 amount to 55 400 000.
For further information please contact: Bellevue Asset Management AG, Seestrasse 16,
8700 Küsnacht / Zurich
Tanja Chicherio, Tel. +41 44 267 67 00.
This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: BB Biotech AG via GlobeNewswire
HUG#2028674
Terms and Privacy Policy